Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis
Advances in Dermatology and Allergology · 2026 · 43 (2) · 203-205
DOI: 10.5114/ada.2026.161103 ↗Kurz gefasst
Leserbrief in der Zeitschrift Advances in Dermatology and Allergology, 2026. Verfasst von Tianqi Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
2/2026 vol. 43 Letter to the Editor Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis Tianqi Wei 1 , Zhimin Duan 1 , Hao Chen 1 , Zhi Xiang 1 , Cheng-Rang Li 1 Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China Adv Dermatol Allergol 2026; XLIII (2): 203–205 DOI: https://doi.org/10.5114/ada.2026.161103 Online publish date: 2026/04/17 View full text Get citation Get citation ENW EndNote BIB JabRef, Mendeley RIS Papers, Reference Manager, RefWorks, Zotero AMA Wei T, Duan Z, Chen H, Xiang Z, Li C. Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(2):203-205. doi:10.5114/ada.2026.161103. APA Wei, T., Duan, Z., Chen, H., Xiang, Z., & Li, C. (2026). Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(2), 203-205. https://doi.org/10.5114/ada.2026.161103 Chicago Wei, Tianqi, Zhimin Duan, Hao Chen, Zhi Xiang, and Cheng-Rang Li. 2026. "Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 43 (2): 203-205. doi:10.5114/ada.2026.161103. Harvard Wei, T., Duan, Z., Chen, H., Xiang, Z., and Li, C. (2026). Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(2), pp.203-205. https://doi.org/10.5114/ada.2026.161103 MLA Wei, Tianqi et al. "Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 43, no. 2, 2026, pp. 203-205. doi:10.5114/ada.2026.161103. Vancouver Wei T, Duan Z, Chen H, Xiang Z, Li C. Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(2):203-205. doi:10.5114/ada.2026.161103.
Autor:innen und Institutionen
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Zitieren
APA
Wei, T., Duan, Z., Chen, H., Xiang, Z., & Li, C. R. (2026). Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology, 43(2), 203-205. https://doi.org/10.5114/ada.2026.161103
Vancouver
Wei T, Duan Z, Chen H, Xiang Z, Li CR. Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology. 2026;43(2):203-205. doi:10.5114/ada.2026.161103
BibTeX
@article{Wei2026,
author = {Wei, Tianqi and Duan, Zhimin and Chen, Hao and Xiang, Zhi and Li, Cheng-Rang},
title = {Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis},
journal = {Advances in Dermatology and Allergology},
year = {2026},
volume = {43},
number = {2},
pages = {203--205},
doi = {10.5114/ada.2026.161103}
}
EUVIMED